Drug
IN 105
IN 105: highest development phase Phase 1, developed by Biocon. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Biocon
Trials
| Drug | Phase | Indication |
|---|---|---|
| IN-105 (Insulin Tregopil) NCT03392961 | Phase 1 | Type 2 Diabetes Mellitus |
| IN-105 NCT01035801 | Phase 1 | Type 1 Diabetes Mellitus |
Latest
No recent events.
Follow IN 105 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.